Dr. Luis Montuenga, new member of the European Academy of Cancer Sciences
This institution, made up of more than 200 European oncologists and researchers, recognizes the outstanding contribution of the scientist from the Cancer Center at Clínica Universidad de Navarra, who will be able to participate in proposals for new European policies against cancer.
PhotoManuelCastells/Dr. Luis Montuenga, in the group laboratory , dedicated to lung research at Cima of Navarra
10 | 12 | 2025
The Dr. Luis Montuenga, researcher Cancer Center Clínica Universidad de Navarra (CCUN), who carries out his scientific work in the Solid Tumors Program at the Cima, has been elected a fellow of the European Academy of Cancer Sciences (EACS). This institution, composed of renowned oncologists and researchers, promotes strategies to improve prevention, early detection, and therapeutic treatments for cancer patients.
With this appointment, EACS members have recognized the contributions of Dr. Montuega, researcher of the group group at Cima. "I feel very honored, and somewhat overwhelmed, to have been elected a member of the Academy by these distinguished European researchers. In reality, it is a recognition of the quality of work all the people who have been part of research lung cancer research team research Cima the Clínica Universidad de Navarraover the years, Clínica Universidad de Navarrasaid the researcher.
The European Academy of Cancer Sciences has more than 200fellows fromover twenty countries, and among the fourteen Spanish members is Dr. Jesús San Miguel, consultant at the CCUN. This small group specialists and researchers submits proposals to European institutions to ensure that health and research policies research to include the fight against cancer among their priorities.
Expert in early detection of lung cancer
graduate doctor of science from the University of Navarra, Dr. Luis Montuenga has focused his research the search for new molecular tools for the early detection and treatment of lung cancer. In his professor career, he is Full Professor Cell Biology at the Schools Science and Medicine at the University of Navarra, was Vice President research the University from 2008 to 2011, and Dean the School Science from 2014 to 2023.
In addition to his work the University of Navarra, he is a member of committee of IdiSNA, group leader group coordinator CIBERONC respiratory tract program, and a member of the European lung research consortia SOLACE and SPACETIME. He also belongs tothe Lung Cancer Policy Networkand the committee the association for the Study of Lung Cancer (IASLC).
